We seek opportunities to combine our scientific capabilities with world-class innovation from government, industry and academia to speed up the development of solutions that will combat the threat of infectious diseases.
The fight against infectious diseases is a global effort, and it is through partnerships that we believe we can
spark a real change.
Given the breadth of public health needs in infectious diseases, through the Johnson & Johnson commitment to Global Public Health, we aim to solve complex global health challenges by using resources and expertise from across our company that combine research and development, access to care and advocacy to advance health around the world.
Biomedical Advanced Research and Development Authority (BARDA)
Walter Reed Army Institute of Research
National Institutes of Health (NIH)
|Charities, foundations, advocacy and patient support groups
Bill & Melinda Gates Foundation
Coalition for Epidemic Preparedness Innovations (CEPI)
Coalition for the Eradication of Viral Hepatitis in Asia Pacific (CEVHAP)
International Partnership for Microbicides
World Hepatitis Alliance
Henry M. Jackson Foundation for the Advancement of Military Medicine
Innovative Medicines Initiative (IMI)
Fred Hutchinson Cancer Research Center
London School of Hygiene and Tropical Medicine
*N.B. This is a sampling of some of Janssen IDV’s key global partnerships and is not an exhaustive list.
Learn more about our commitment to Global Public Health and access to medicines initiatives here.